Oncology PracticeTucatinib called game-changer in HER2-positive metastatic breast cancerDecember 12, 2019Breast Cancer
Oncology PracticeTrastuzumab deruxtecan has good activity in advanced HER2-positive breast cancerDecember 12, 2019Breast Cancer
Oncology PracticeNovel agent boosts adjuvant therapy for high-risk breast cancerDecember 12, 2019Breast Cancer
Oncology PracticeFailed ATEMPT: T-DM1 no safer in early HER2+ breast cancerDecember 12, 2019Breast Cancer
Oncology PracticeAdjuvant denosumab falls short in early-stage breast cancerDecember 9, 2019Breast Cancer
Oncology PracticeBilateral mastectomy reduces second breast cancer risk, but not deathsDecember 6, 2019Breast Cancer
Oncology PracticeSurvival gains in HR+/HER2– MBC trials yet to be seen in real worldDecember 4, 2019Breast Cancer
Oncology PracticeSingle-fraction radiation just misses mark for spinal compression reliefDecember 4, 2019Breast CancerLung CancerGenitourinary Cancer
Oncology PracticeSupplemental MRI found to benefit women with dense breast tissueNovember 27, 2019Breast CancerPreventive Care
Oncology PracticeStudy detects lower CV risk in breast cancer survivorsNovember 14, 2019Breast CancerPatient & Survivor Care
Oncology PracticeMolecule exhibits activity in heavily pretreated, HER2-positive solid tumorsNovember 11, 2019Breast CancerGynecologic CancerGastroenterologyImmunotherapyImmuno-oncologyGastrointestinal Cancer
‘You had me at hello’: ESMO studies confirm survival benefits in NSCLC and breast cancerNovember 11, 2019Lung CancerBreast Cancer
Oncology PracticeA progressive exercise intervention improved AGFR in breast cancer survivorsNovember 8, 2019Breast Cancer
Oncology PracticeExercise improved QoL, functioning in breast cancer survivorsNovember 8, 2019Breast CancerPatient & Survivor Care
